The Flint water crisis resulted from simultaneous failures of the federal Safe Drinking Water Act and Michigan’s Local Financial Stability and Choice Act.

The innovative new system demonstrates success in distracting the harmful spores before they have begun to grow and disrupt a wheat crop.

Bats are often considered patient zero for many deadly viruses affecting humans, including Ebola, rabies, and, most recently, the SARS-CoV-2 strain of virus that causes coronavirus.

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Researchers at MIT and Brigham and Women’s Hospital have designed a new face mask that they believe could stop viral particles as effectively as N95 masks.

Heat indices will make it feel like 100+ degrees across most of the South for the next week.

A team of Carnegie Mellon researchers found that Pittsburgh’s air pollution levels decreased during the stay-at-home order—but the overall impact remains small.

Concentrations of sulphur dioxide in polluted areas in India have decreased by around 40% between April 2019 and April 2020.

New research has identified the specific brain cells that control how much sugar you eat and how much you crave sweet tasting food

Lopinavir is a drug against HIV, hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs were regarded as potential agents in the fight against the coronavirus SARS-CoV-2. A research group from the University of Basel and the University Hospital Basel has now discovered that the concentration of the two drugs in the lungs of Covid-19 patients is not sufficient to fight the virus.

In February 2020, a Covid-19 patient cohort was established at the University and the University Hospital in Basel to prospectively monitor a range of diagnostic means and potential treatments for Covid-19, including the off-label use of hydroxychloroquine and lopinavir/ritonavir.

A research group monitored lopinavir plasma levels in Covid-19 patients. “Considering that substantial inflammation was observed in these patients, and previous studies have shown the inhibition of drug metabolism by systemic inflammation, we had the rationale to investigate the effect of inflammation on lopinavir and hydroxychloroquine plasma levels,” states Professor Catia Marzolini, first author of the study and professor for experimental medicine at the University of Basel.

Read more at: University of Basel

Treatment of a patient with Covid-19 in the intensive care unit of the University Hospital Basel. (Photo Credit: University Hospital Basel, Fabian Fiechter)